|
|
News Breaks
|
November 19, 2009
|
| 07:15 EDT |  | CELG |
| theflyonthewall.com: | Celgene earnings and sales growth guidance achievable, says Citigroup | | Citigroup believes investors are concerned that Celgene's 2009-2012 sales and earnings growth guidance is not achievable. However, after reviewing its estimates, Citi believes the guidance can be met through Revlimid's global expansion, treatment duration increase and price increases. The firm keeps a Buy rating on the stock. :theflyonthewall.com |
|
|
News For CELG From The Last 14 Days Check below for free stories on CELG the last two weeks.
There are 8 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 10, 2012
|
| 10:01 EDT |  | CELG |
| | 06:36 EDT |  | CELG |
|
|
February 9, 2012
|
| 08:10 EDT |  | CELG |
|
|
February 6, 2012
|
| 13:00 EDT |  | CELG |
|
|
January 31, 2012
|
| 11:21 EDT |  | CELG |
|
|
January 27, 2012
|
| 08:38 EDT |  | CELG |
| | 08:08 EDT |  | CELG |
| | 07:31 EDT |  | CELG |
|
|
|
|
|